GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » EBITDA Margin %

Zahravi Pharmacutical Co (XTEH:DZAH1) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Zahravi Pharmacutical Co's EBITDA for the six months ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Zahravi Pharmacutical Co's EBITDA margin for the quarter that ended in . 20 was 0.00%.


Zahravi Pharmacutical Co EBITDA Margin % Historical Data

The historical data trend for Zahravi Pharmacutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co EBITDA Margin % Chart

Zahravi Pharmacutical Co Annual Data
Trend
EBITDA Margin %

Zahravi Pharmacutical Co Semi-Annual Data
EBITDA Margin %

Competitive Comparison of Zahravi Pharmacutical Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Zahravi Pharmacutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zahravi Pharmacutical Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zahravi Pharmacutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Zahravi Pharmacutical Co's EBITDA Margin % falls into.



Zahravi Pharmacutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Zahravi Pharmacutical Co's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Zahravi Pharmacutical Co's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co  (XTEH:DZAH1) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Zahravi Pharmacutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines